Impact of guideline adherence on the prognosis of Barcelona clinic liver cancer stage B hepatocellular carcinoma

doi:10.3748/wjg.v29.i47.6122

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 29, Issue 47

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2257)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-6) series.

Item

Count

PDF

WORD

HTML

1295

Figures (1-5)

140

Tables (1-6)

122

Sum=1644

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

426

Sum=525

Dec 21, 2023 (publication date) through Jul 24, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Dec 21, 2023; 29(47): 6122-6137
Published online Dec 21, 2023. doi: 10.3748/wjg.v29.i47.6122

Full Size Figure Download Figure

Figure 2 Changes in the rate of adherence to hepatocellular carcinoma guidelines over time. AASLD: American Association for the Study of Liver Diseases; APASL: Asian Pacific Association for the Study of the Liver; EASL: European Association for the Study of the Liver; HCC: Hepatocellular carcinoma.

Citation: Han JE, Cho HJ, Cheong JY, Lim SG, Yang MJ, Noh CK, Lee GH, Kim SS. Impact of guideline adherence on the prognosis of Barcelona clinic liver cancer stage B hepatocellular carcinoma. World J Gastroenterol 2023; 29(47): 6122-6137
URL: https://www.wjgnet.com/1007-9327/full/v29/i47/6122.htm
DOI: https://dx.doi.org/10.3748/wjg.v29.i47.6122